Idiopathic Portal Hypertension in Patients with HIV Infection Treated with Highly Active Antiretroviral Therapy

American Journal of Gastroenterology

Volumn 104, Issue 7, 2009, Pages 1707-1714

  Chang, Pik Eu ^a   Miquel, Rosa ^a   Blanco, Jose Luis ^a   Laguno, Montserrat ^a   Bruguera, Miguel ^b   Abraldes, Juan G ^a,b   Bosch, Jaime ^a,b   Garcia Pagan, Juan Carlos ^a,b  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR PHOSPHATE; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; INDINAVIR; LAMIVUDINE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; TENOFOVIR; VIRUS DNA; VIRUS RNA; ZIDOVUDINE;

ADULT; AGED; ARTICLE; ASCITES; CLINICAL ARTICLE; FEMALE; HEMODYNAMIC MONITORING; HEPATIC VENOUS PRESSURE GRADIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IDIOPATHIC DISEASE; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER SINUSOID; LIVER STIFFNESS; MALE; PORTAL HYPERTENSION; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; SPLENOMEGALY; VARICOSIS; VASCULAR DISEASE; VENOUS PRESSURE;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BLOOD CHEMICAL ANALYSIS; CONFIDENCE INTERVALS; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HEMODYNAMICS; HIV INFECTIONS; HUMANS; HYPERTENSION, PORTAL; IMMUNOHISTOCHEMISTRY; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PROBABILITY; REGISTRIES; RISK ASSESSMENT; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 67650450829     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.165     Document Type: Article

References (38)

1. Okuda K. Non-cirrhotic portal hypertension vs. idiopathic portal hypertension. J Gastroenterol Hepatol 2002;17:S204-13.
2. Nakanuma Y, Hoso M, Sasaki M et al. Histopathology of the liver in non-cirrhotic portal hypertension of unknown aetiology. Histopathology 1996;28:195-204.
3. Ludwig J, Hashimoto E, Obata H et al. Idiopathic portal hypertension; a histopathological study of 26 Japanese cases. Histopathology 1993;22: 227-34.
4. Sarin SK, Kapoor D. Non-cirrhotic portal fibrosis: current concepts and management. J Gastroenterol Hepatol 2002;17:526-34.
5. Hillaire S, Bonte E, Denninger MH et al. Idiopathic non-cirrhotic intrahe-patic portal hypertension in the West: a re-evaluation in 28 patients. Gut 2002;51:275-80.
6. Datta DV, Mitra SK, Chhuttani PN et al. Chronic oral arsenic intoxication as a possible aetiological factor in idiopathic portal hypertension (non-cirrhotic portal fibrosis) in India. Gut 1979;20:378-84.
7. Smith PM, Crossley IR, Williams DM. Portal hypertension in vinyl-chloride production workers. Lancet 1976;2:602-4.
8. Maida I, Nunez M, Rios MJ et al. Severe liver disease associated with prolonged exposure to antiretroviral drugs. J Acquir Immune Defic Syndr 2006;42:177-82.
9. Mallet V, Blanchard P Verkarre V et al. Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients. AIDS 2007;21:187-92.
10. Schiano TD, Kotler DP, Ferran E et al. Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV. Am J Gastroenterol 2007;102:2536-40.
11. Maida I, Garcia-Gasco P Sotgiu G et al. Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome. Antiviral Therapy 2008;13:103-7.
12. Saifee S, Joelson D, Braude J et al. Noncirrhotic portal hypertension in patients with human immunodeficiency virus-1 infection. Clin Gastroenterol Hepatol 2008;6:1167-9.
13. Perello A, Garcia-Pagan JC, Gilabert R et al. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology 2002;35:132-9.
14. Espinosa G, Font J, Garcia-Pagan JC et al. Budd-Chiari syndrome secondary to antiphospholipid syndrome: clinical and immunological characteristics of 43 patients. Medicine (Baltimore) 2001;80:345-54.
15. Arena U, Vizzutti F, Abraldes JG et al. Reliability of transient elastog-raphy for the diagnosis of advanced fibrosis in chronic hepatitis C. Gut 2008;57:1288-93.
16. Kazemi F, Kettaneh A, N'kontchou G et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol 2006;45:230-5.
17. Vizutti F, Arena U, Romanelli RG et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007;45:1290-7.
18. Palella FJ, Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced HIV infection. HIV Outpatients Study Investigators. N Engl J Med 1998;338:853-60.
19. The CASCADE collaboration. Survival after introduction of HAART in people with known duration of HIV-1 infection. Lancet 2000;355:1158-9.
20. Bica I, McGovern B, Dhar R et al. Increasing mortality due to end-stage liver disease in patients with HIV infection. Clin Infect Dis 2001;32:492-7.
21. Castellares C, Barreiro P, Martín-Carbonero L et al. Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome. J Viral Hepat 2008;15:165-72.
22. Gonzalez SA, Talal AH. Hepatitis C virus in human immunodeficiency virus-infected individuals: an emerging comorbidity with significant implications. Semin Liver Dis 2003;23:149-66.
23. Sarin SK, Sethi KK, Nanda R. Measurement and correlation of wedged hepatic, intrahepatic, intrasplenic and intravariceal pressure in patients with cirrhosis of the liver and non-cirrhotic portal fibrosis. Gut 1997;28:620-5.
24. Bosch J, Garcia-Pagan JC, Berzigotti A et al. Measurement of portal pressure and its role in the management of chronic liver disease. Sem Liver Dis 2006;26:348-62.
25. Futagawa S, Fukazawa M, Musha H et al. Hepatic venography in noncirrhotic idiopathic portal hypertension. Comparison with cirrhosis of the liver. Radiology 1981;141:303-9.
26. Sharma P, Kumar A, Mehta V et al. Systemic and pulmonary hemody-namics in patients with non-cirrhotic portal fibrosis (NCPF) is similar to compensated cirrhosis. Hep Intl 2007;1:275-80.
27. Okuda K, Nakashima T, Okudaira M et al. Liver pathology of idiopathic portal hypertension. Comparison with non-cirrhotic portal fibrosis of India. The Japan idiopathic portal hypertension study. Liver 1982;2:176-92.
28. Nakanuma Y, Tsuneyama K, Ohbu M et al. Pathology and pathogenesis of idiopathic portal hypertension with an emphasis on the liver. Pathol Res Pract 2001;197:65-76.
29. Ibarrola C, Colina F. Clinicopathological features of nine cases of noncirrhotic portal hypertension: current definitions and criteria are inadequate. Histopathology 2003;42:251-64.
30. Okudaira M, Ohbu M, Okuda K. Idiopathic portal hypertension and its pathology. Semin Liver Dis 2002;22:59-72.
31. Sciot R, Straessen D, Van Damme B et al. Incomplete septal cirrhosis: histopathological aspects. Histopathology 1988;13:593-603.
32. Geller SA, Dubinsky MC, Poordad FF et al. Early hepatic nodular hyperplasia and submicroscopic fibrosis associated with 6-thioguanine therapy in inflammatory bowel disease. Am J Surg Pathol 2004;28:1204-11.
33. Mehta NJ, Khan IA, Mehta RN et al. HIV-related pulmonary hypertension.: analytic review of 131 cases. Chest 2000;118:1133-41.
34. Pellicelli AM, Palmieri F, Cicalini S et al. Pathogenesis of HIV-related pulmonary hypertension. Ann NY Acad Sci 2001;946:82-94.
35. Matsutani S, Maruyama H, Akiike T et al. Study of portal vein thrombosis in patients with idiopathic portal hypertension in Japan. Liver Int 2005;25:978-83.
36. Majluf-Cruz A, Silva-Estrada M, Sanchez-Barboza R et al. Venous thrombosis among patients with AIDS. Clin Appl Thromb Hemost 2004;10:19-25.
37. Mallet V Varthaman A, Lasne D et al. Human immunodeficiency virus-associated nodular regenerative hyperplasia is linked to portal obstructive venopathy and auto-immune protein S deficiency. Hepatology 2007;46 (Suppl): 576A (Abstract).
38. Grossman W Blood flow measurement: cardiac output and vascular resistance. In: Baim DS, Grossman W (eds). Grossman's Cardiac Catheterisation, Angiography and Intervention, 7th edn, Lippincott Williams and Wilkins: Boston, MA, 2005, pp. 148-62. 1787